About 1 result found for searched term "Amivantamab" (0.125 seconds)
Cat.No. | Name | Target |
---|---|---|
M24975 | Amivantamab | EGFR/HER2 |
JNJ-61186372 | ||
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.